Five Prime Therapeutics Inc Asset Turnover Ratio (FPRX), as of fourth quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Five Prime Therapeutics Inc   (NASDAQ: FPRX)
 

Five Prime Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2020, Five Prime Therapeutics Inc has not recorded any assets.
Visit Five Prime Therapeutics Inc Balance sheet

Within sector 221 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2020 compared to the preceding quarter from 3550 to 4075.

Asset Turnover Ratio Definition



FPRX Asset Turnover Ratio (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Asset Change 38.58 % -44.85 % -46.3 % -35.83 % -30.29 %
Y / Y Revenue Change - -31.37 % 2.73 % 57.36 % -2.07 %
Asset Turnover Ratio (TTM) - 0.09 0.09 0.07 0.05
FPRX's Total Ranking # 4075 # 3550 # 3626 # 3692 # 4188
Seq. Asset Change 117.83 % -9.08 % -22.57 % -9.63 % -13.3 %
Seq. Revenue Change - -40.19 % -59.31 % 162.12 % 7.57 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 222
Healthcare Sector # 575
Overall Market # 4075

Asset Turnover Ratio Statistics
High Average Low
1.28 0.23 0.05
(Dec 31 2015)   (Sep 30 2019)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Assets at quarter ending Dec 31 2020
Catheter Precision Inc   0.11 $ 4.405  Millions$ 38.471  Millions
Electrocore Inc   0.11 $ 3.496  Millions$ 30.904  Millions
Novan Inc   0.11 $ 4.920  Millions$ 44.192  Millions
Capforce Inc   0.11 $ 4.214  Millions$ 40.127  Millions
Legend Biotech Corporation  0.10 $ 75.676  Millions$ 721.007  Millions
Biohaven Ltd   0.10 $ 63.627  Millions$ 606.478  Millions
Ethema Health Corporation   0.10 $ 0.339  Millions$ 3.241  Millions
Bionik Laboratories Corp   0.10 $ 1.654  Millions$ 15.851  Millions
Accelerate Diagnostics Inc   0.10 $ 11.165  Millions$ 108.113  Millions
Vir Biotechnology Inc   0.10 $ 76.368  Millions$ 752.843  Millions
Uniqure N v   0.10 $ 37.514  Millions$ 372.621  Millions
Adaptive Biotechnologies Corporation  0.10 $ 98.382  Millions$ 985.399  Millions
Harpoon Therapeutics Inc   0.10 $ 17.444  Millions$ 178.633  Millions
Aveo Pharmaceuticals Inc   0.09 $ 6.019  Millions$ 63.521  Millions
Nektar Therapeutics  0.09 $ 152.915  Millions$ 1,632.561  Millions
Syros Pharmaceuticals Inc   0.09 $ 15.093  Millions$ 163.950  Millions
Nabriva Therapeutics Plc  0.09 $ 5.027  Millions$ 55.315  Millions
Dermtech Inc   0.09 $ 5.885  Millions$ 65.866  Millions
Lexicon Pharmaceuticals Inc   0.09 $ 23.995  Millions$ 268.956  Millions
Solana Company  0.09 $ 0.661  Millions$ 7.435  Millions
Old Ayala Inc   0.08 $ 3.708  Millions$ 43.665  Millions
Mymetics Corporation  0.08 $ 0.748  Millions$ 8.828  Millions
Galapagos Nv  0.08 $ 535.419  Millions$ 6,403.859  Millions
Revolution Medicines Inc   0.08 $ 42.983  Millions$ 517.692  Millions
Alpine Immune Sciences Inc   0.08 $ 9.346  Millions$ 112.667  Millions
Biocryst Pharmaceuticals Inc   0.08 $ 17.812  Millions$ 215.559  Millions
Delcath Systems Inc   0.08 $ 1.646  Millions$ 20.355  Millions
Shattuck Labs Inc   0.08 $ 9.934  Millions$ 123.539  Millions
Aclaris Therapeutics Inc   0.08 $ 6.482  Millions$ 81.124  Millions
Arbutus Biopharma Corp  0.08 $ 6.914  Millions$ 87.565  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.